603718 *ST海利生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.717-25.50112.3265.33411.334
总资产报酬率 ROA (%)0.534-21.1009.8253.9647.242
投入资产回报率 ROIC (%)0.601-23.85511.8545.05110.793

边际利润分析
销售毛利率 (%)64.67672.17260.20451.39458.969
营业利润率 (%)19.406-310.55864.39122.91923.309
息税前利润/营业总收入 (%)20.811-100.06074.19724.41746.493
净利润/营业总收入 (%)16.871-155.51267.01420.77636.898

收益指标分析
经营活动净收益/利润总额(%)87.783-26.04214.352-12.3666.497
价值变动净收益/利润总额(%)0.887-2.48269.982101.0728.615
营业外收支净额/利润总额(%)-0.506-215.68816.1401.52146.711

偿债能力分析
流动比率 (X)4.2665.3426.9011.3492.073
速动比率 (X)3.7574.8096.3521.1021.622
资产负债率 (%)25.05320.3666.76829.13326.630
带息债务/全部投入资本 (%)8.2271.3860.8430.619-2.041
股东权益/带息债务 (%)984.2996,278.16011,585.74115,234.977-4,661.548
股东权益/负债合计 (%)283.271384.9301,262.056251.985282.786
利息保障倍数 (X)13.85259.389-28.67421.34416.889

营运能力分析
应收账款周转天数 (天)207.522200.502128.418136.280112.325
存货周转天数 (天)349.178394.100263.391381.076420.438